Missouri State University
Springfield - 91.1
Branson - 90.5
West Plains - 90.3
Mountain Grove - 88.7
Joplin - 98.9
Neosho - 103.7
Share |

It look's like you don't have Adobe Flash Player installed. Get it now.

St. John's Medical Research is Conducting a Study to Test a Medication for Men with Osteoporosis


St. John's Medical Research is looking for participants for a clinical research study evaluating a medication for the treatment of male osteoporosis. Osteoporosis is a disease that deteriorates bone tissue and causes a loss in bone density. KSMU's Joe Morgan spoke with a study participant as well as the doctor conducting the study.

According to St. John's Medical Research, one in four men over the age of fifty will experience an osteoporosis related fracture in his lifetime. Osteoporosis can have serious consequences for men often resulting in increased rates of morbidity and mortality compared to women. Dr. Gregory Ledger says that men with osteoporosis are more likely to experience serious consequences than women.

Ledger says that osteoporosis in women is caused usually by a lack of estrogen but the cause for men can range from heredity to lack of a healthy lifestyle.

Ledger says there is only one FDA approved medication on the market for men with osteoporosis and he hopes this study helps put another medication on the market.

Michael Hickam was diagnosed with osteoporosis in 2003 and was told it was hereditary. He has volunteered to be a part of the study and he explains why.

Hickam explains what he hopes he will get out of the study as well as what he hopes the study will find.

The study is open to men 30 years of age or older who have been diagnosed with osteoporosis or are considered at risk for osteoporosis due to family history or frequent recurring injuries to bones, hips or joints. The phone number for questions regarding the study is 417-841-0250. For KSMU News, I'm Joe Morgan.